In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Premier Inc.

Drug Shortage Legislation Gains Support As Coronavirus Threatens US Supplies

Coronavirus hysteria sweeps up languishing drug shortage legislation; prospects for new reporting and risk management planning requirements improve.

Manufacturing Quality

Azar Tapped: Stakeholders Heap Praise On Trump HHS Nominee

The administration's nominee to head HHS is being praised by medtech health-care industry lobbyists but may experience some pushback in the Senate because of his ties to Eli Lilly.

Policy Appointments

Biosimilars Education: Oncobiologics/Premier Deal Aims To Boost Adoption, Data Collection

With two biosimilars set to move into Phase III this year, Oncobiologics hopes partnership with hospital services firm Premier will generate 'best practices around the optimal use of these cost-effective treatments.'

Business Strategies Advertising, Marketing & Sales

Hospital Survey Sheds Light On New Era Of Accountable Care

In Premier Inc.’s new survey, hospitals and health systems project a significant shift in 2013 admissions from inpatient to outpatient settings as these sites transition toward new care delivery models.

United States
See All

Company Information

  • Industry
  • Services
    • Outcomes Studies
    • Services sold to health care facilities
UsernamePublicRestriction

Register